▲ Peaking
Business
Shionogi to Acquire IntraBio for $2 Billion
Shionogi is expanding its rare disease portfolio through a $2 billion acquisition of Texas-based biotech firm IntraBio.
Intrabio
1 trends tracked about this subject — the full history, oldest to newest below.